Lixisenatide

Lyxumia 20 Microgramos Solucion Inyectable

0,100 MG/ML - solución inyectableSpainAuthorisedAuthorised 12 Feb 2013

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lixisenatide

Lyxumia 20 Microgramos Solucion Inyectable

0,100 MG/ML - solución inyectableSpainAuthorisedAuthorised 12 Feb 2013

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

AdlyxineCanada · 10 MCG / ACT · Solution · Sanofi-Aventis Canada INC

AdlyxineCanada · 20 MCG / ACT · Solution · Sanofi-Aventis Canada INC

AdlyxinUnited States · 0.15MG/3ML, 0.3MG/3ML · solution · Sanofi-Aventis US

Packs

Pack	Code	Status
LYXUMIA 20 MICROGRAMOS SOLUCION INYECTABLE, 2 plumas precargadas de 14 dosis	696752

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lixisenatide
Strength: 0,100 MG/ML -
Dosage form: solución inyectable
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 12 Feb 2013
Registration: 12811003
Marketing authorisation holder: Sanofi Winthrop Industrie
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica

Spain